Implantable left ventricular assist systems (LVAS): Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure

Paul Mohacsi, Mario C. Deng, Richard Murphy, Claes Håkan Bergh, Edoardo Gronda, Michel Komajda, Richard Pacher, Jindrich Spinar, Karl Swedberg, John F. Cleland

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Implantable left ventricular assist systems (LVAS) consist of implantable pumps with small control consoles and power sources that can be worn externally. These systems provide far greater patient mobility and independence than external pumps with bulky control consoles. Patients with implantable LVAS can be discharged from hospital and are able to return to work and resume active sports. Most patients have received these systems as a bridge to heart transplantation. Clinical status and quality of life improve dramatically after device implantation and survival on support (60-70% after approx. 100 days of support) is acceptable compared with transplant candidates on medical therapy. Patient selection and adverse events, primarily bleeding, thromboembolism and infection, are important issues with LVAS. In the future, long-term support and bridging to myocardial recovery may become important indications for LVAS. (C) 2000 European Society of Cardiology.

Original languageEnglish
Pages (from-to)13-18
Number of pages6
JournalEuropean Journal of Heart Failure
Volume2
Issue number1
DOIs
Publication statusPublished - Mar 1 2000

Fingerprint

Heart Failure
Myocardial Bridging
Electric Power Supplies
Return to Work
Thromboembolism
Heart Transplantation
Patient Selection
Sports
Quality of Life
Hemorrhage
Transplants
Equipment and Supplies
Survival
Infection
Therapeutics

Keywords

  • Advanced heat failure (AHF)
  • Left ventricular assist systems (LVAS)
  • Mechanical circulatory support (MCS)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Implantable left ventricular assist systems (LVAS) : Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure. / Mohacsi, Paul; Deng, Mario C.; Murphy, Richard; Bergh, Claes Håkan; Gronda, Edoardo; Komajda, Michel; Pacher, Richard; Spinar, Jindrich; Swedberg, Karl; Cleland, John F.

In: European Journal of Heart Failure, Vol. 2, No. 1, 01.03.2000, p. 13-18.

Research output: Contribution to journalArticle

Mohacsi, Paul ; Deng, Mario C. ; Murphy, Richard ; Bergh, Claes Håkan ; Gronda, Edoardo ; Komajda, Michel ; Pacher, Richard ; Spinar, Jindrich ; Swedberg, Karl ; Cleland, John F. / Implantable left ventricular assist systems (LVAS) : Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure. In: European Journal of Heart Failure. 2000 ; Vol. 2, No. 1. pp. 13-18.
@article{4c14c708a5ef4b2387668dd6786b3bd4,
title = "Implantable left ventricular assist systems (LVAS): Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure",
abstract = "Implantable left ventricular assist systems (LVAS) consist of implantable pumps with small control consoles and power sources that can be worn externally. These systems provide far greater patient mobility and independence than external pumps with bulky control consoles. Patients with implantable LVAS can be discharged from hospital and are able to return to work and resume active sports. Most patients have received these systems as a bridge to heart transplantation. Clinical status and quality of life improve dramatically after device implantation and survival on support (60-70{\%} after approx. 100 days of support) is acceptable compared with transplant candidates on medical therapy. Patient selection and adverse events, primarily bleeding, thromboembolism and infection, are important issues with LVAS. In the future, long-term support and bridging to myocardial recovery may become important indications for LVAS. (C) 2000 European Society of Cardiology.",
keywords = "Advanced heat failure (AHF), Left ventricular assist systems (LVAS), Mechanical circulatory support (MCS)",
author = "Paul Mohacsi and Deng, {Mario C.} and Richard Murphy and Bergh, {Claes H{\aa}kan} and Edoardo Gronda and Michel Komajda and Richard Pacher and Jindrich Spinar and Karl Swedberg and Cleland, {John F.}",
year = "2000",
month = "3",
day = "1",
doi = "10.1016/S1388-9842(00)00055-6",
language = "English",
volume = "2",
pages = "13--18",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "John Wiley & Sons, Ltd",
number = "1",

}

TY - JOUR

T1 - Implantable left ventricular assist systems (LVAS)

T2 - Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure

AU - Mohacsi, Paul

AU - Deng, Mario C.

AU - Murphy, Richard

AU - Bergh, Claes Håkan

AU - Gronda, Edoardo

AU - Komajda, Michel

AU - Pacher, Richard

AU - Spinar, Jindrich

AU - Swedberg, Karl

AU - Cleland, John F.

PY - 2000/3/1

Y1 - 2000/3/1

N2 - Implantable left ventricular assist systems (LVAS) consist of implantable pumps with small control consoles and power sources that can be worn externally. These systems provide far greater patient mobility and independence than external pumps with bulky control consoles. Patients with implantable LVAS can be discharged from hospital and are able to return to work and resume active sports. Most patients have received these systems as a bridge to heart transplantation. Clinical status and quality of life improve dramatically after device implantation and survival on support (60-70% after approx. 100 days of support) is acceptable compared with transplant candidates on medical therapy. Patient selection and adverse events, primarily bleeding, thromboembolism and infection, are important issues with LVAS. In the future, long-term support and bridging to myocardial recovery may become important indications for LVAS. (C) 2000 European Society of Cardiology.

AB - Implantable left ventricular assist systems (LVAS) consist of implantable pumps with small control consoles and power sources that can be worn externally. These systems provide far greater patient mobility and independence than external pumps with bulky control consoles. Patients with implantable LVAS can be discharged from hospital and are able to return to work and resume active sports. Most patients have received these systems as a bridge to heart transplantation. Clinical status and quality of life improve dramatically after device implantation and survival on support (60-70% after approx. 100 days of support) is acceptable compared with transplant candidates on medical therapy. Patient selection and adverse events, primarily bleeding, thromboembolism and infection, are important issues with LVAS. In the future, long-term support and bridging to myocardial recovery may become important indications for LVAS. (C) 2000 European Society of Cardiology.

KW - Advanced heat failure (AHF)

KW - Left ventricular assist systems (LVAS)

KW - Mechanical circulatory support (MCS)

UR - http://www.scopus.com/inward/record.url?scp=0034040277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034040277&partnerID=8YFLogxK

U2 - 10.1016/S1388-9842(00)00055-6

DO - 10.1016/S1388-9842(00)00055-6

M3 - Article

C2 - 10742698

AN - SCOPUS:0034040277

VL - 2

SP - 13

EP - 18

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 1

ER -